Lipoteichoic acid : Augmentation of the therapeutic effect of radiation and 5-fluorouracil in head and neck cancer
Lipoteichoic acid : Augmentation of the therapeutic effect of radiation and 5-fluorouracil in head and neck cancer
批准号:
09557170
负责人:
SATO Mitsunobu
金额:
$7.55万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1. Interferon (IFN-γ-inducing molecule (OK-LTA) has been purified from the streptococcal agent OK-432, by an affinity chromatography on CNBr-activated Sepharose 4B bound the TS-2 monoclonal antibody which neutralizes IFN-γ-inducing activity of OK-432. The OK-LTA is a glyco-conjugate with a certain structure of lipoteichoic acids. OK-LTA carried striking antitumor activity in vivo and in vitro.2. OK-LTA induced several cytokines such as IFN-α,-β,-γ, tumor necrosis factor(TNF)-α,-β, interleukin(IL)-2, IL-6, IL-12, IL-18, as well as natural killer(NK) and lymphokine-activated killer(LAK) activities on human peripheral blood mononuclear cells(PBMC).3. Nude mice bearing human head and neck cancer cells were treated with X-ray(10Gy), 5-FU(40mg/Kg), and/or OK-LTA. It was sugested that the anti-tumor effect of 5-FU were enhanced by OK-LTA.4. The negative liposome kit (egg lecithin : dicethyphosphate : cholesterol = 7 : 2 : 1, molar ratio) was used to improve the delivery of the agent (OK-LTA) to effector cells and to increase its therapeutic effect. The significantly lesser amounts of OK-LTA encapsulated into liposomes (Lipo-OK-LTA) than OK-LTA alone (1/100 or less amounts of OK-LTA alone) were required to induce IFN-γ, TNF-α,-β, IL-1β, NK, and LAK activities by human PBMC as well as by mouse spleen cells (MSC). Furthermore, higher levels of these activities were detected in PBMC and MSC treated with Lipo-OK-LTA than with OK-LTA alone.5. All of these activities induced by Lipo-OK-LTA were almost completely neutralized by anti-asialo-GM1 antibody and complement (P<0.001). In in vivo experiments, it was clearly indicated that Lipo-OK-LTA significantly accelerated anti-tumor ability of X-ray and 5-FU.
期刊论文(88)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Azuma M: "Enhancement of bFGF export associated with malignant progression of human salivary gland cell clones."Int J Cancer. 71(5). 891-896 (1997)
Azuma M:“bFGF 输出的增强与人类唾液腺细胞克隆的恶性进展相关。”Int J Cancer。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sato M: "Therapy for oral squamous cell carcinoma by tegafur and streptococcal agent OK-432 in combination with radiotherapy: Association of the therapeutic effect with differentiation and apoptosis in the cancer cells."Apoptosis. 2(2). 227-238 (1997)
Sato M:“替加氟和链球菌制剂 OK-432 联合放疗治疗口腔鳞状细胞癌:治疗效果与癌细胞分化和凋亡的关联。”细胞凋亡。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hoque MO: "Significant correlation between matrix metalloproteinase activity and tumor necrosis factor-αin salivary extravasation mucoceles."J Oral Pathol Med. 27(1). 30-33 (1998)
Hoque MO:“唾液外渗粘液囊肿中基质金属蛋白酶活性与肿瘤坏死因子-α 之间的显着相关性。”J Oral Pathol Med 27(1)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Azuma M: "TGF-β1 inhibits NF-kB activity through induction of IkB-αexpression in human salivary gland cells."Exp Cell Res. 250(1). 213-222 (1999)
Azuma M:“TGF-β1 通过诱导人唾液腺细胞中的 IkB-α 表达来抑制 NF-kB 活性。”Exp Cell Res 250(1)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hoque MO: "Significant correlation between matrix metalloproteinase activity and tumor necrosis factor-α in salivary extravasation mucoceles."J Oral Pathol Med. 77(3). 269-280 (1997)
Hoque MO:“唾液外渗粘液囊肿中基质金属蛋白酶活性与肿瘤坏死因子-α 之间的显着相关性。”J Oral Pathol Med 77(3) (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 79 条
Syntheses of apatite via Ca complexes of amino acids involved innon-collagen protein
-
批准号:22550183
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2010
-
负责人:SATO Mitsunobu
-
依托单位:
Toll-like receptor 4 signaling : Enhancement of therapeutic effect of anti-cancer drugs and radiation in oral Cancer
-
批准号:14207090
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$32.28万
-
财政年份:2002
-
负责人:SATO Mitsunobu
-
依托单位:
Development of the therapy for oral cancer by transduction of iNOS gene in combination with radiotherapy
-
批准号:12557176
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.66万
-
财政年份:2000
-
负责人:SATO Mitsunobu
-
依托单位:
Study on differentiation and apoptosis-inducing therapy for head and neck cancer by vesnarinone
-
批准号:10307051
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$25.81万
-
财政年份:1998
-
负责人:SATO Mitsunobu
-
依托单位:
Detection of Novel Drug Receptor and Mechanism of Induction of Differentiation and Apoptosis in Human Salivary Cancer Cells
-
批准号:06404072
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$19.46万
-
财政年份:1994
-
负责人:SATO Mitsunobu
-
依托单位:
Development of screening system for searching cellular differentiation-inducing agents by utlizing human salivary cancer cells
-
批准号:05557084
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$7.04万
-
财政年份:1993
-
负责人:SATO Mitsunobu
-
依托单位:
Study of Differentiation Therapy for Salivary Gland Cancer
-
批准号:03454467
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.48万
-
财政年份:1991
-
负责人:SATO Mitsunobu
-
依托单位:
Development of Multi-functional Ligands for Application of Metal Complexes
-
批准号:03650687
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.09万
-
财政年份:1991
-
负责人:SATO Mitsunobu
-
依托单位:
Local Immunotherapy of Oral Cancer with LAK Cells and Interleukin 2
-
批准号:63870080
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$6.14万
-
财政年份:1988
-
负责人:SATO Mitsunobu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
OSMI-4靶向O-糖基化调控PD-L1联合裂解OK-432协同治疗不完全消融后残存肝癌的机制研究
-
批准号:JCZRLH202600261
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
OK-432联合PD-1单抗治疗肝癌射频消融后残存和远处转移瘤的机制及疗效研究
-
批准号:82072041
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:阚雪锋
-
依托单位:
OK-432和西地那非治疗儿童淋巴管畸形机制的探讨
-
批准号:81300238
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:侯昉
-
依托单位:
OK-432肿瘤疫苗抗肿瘤作用的信号传导机制
-
批准号:81141091
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2011
-
负责人:李宪起
-
依托单位: